Skip to main content

Severe Sinus Congestion

NDC 0363-6150 · Walgreen Company

Generic nameAcetaminophen, Guaifenesin, Phenylephrine HCl
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength325; 200; 5 mg/1; mg/1; mg/1
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

0363-6150-09 — 2 BLISTER PACK in 1 CARTON (0363-6150-09) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-5410 — ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE, 0363-5430 — ACETAMINOPHEN, DIPHENHYDRAMINE HCl, PHENYLEPHRINE HCl, 0363-5470 — ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl, 0363-5527 — Dextromethorphan HBr, Guaifensin, 0363-6002 — acetaminophen, 0363-6005 — Dextromethorphan Hydrobromide and Guaifenesin, 0363-6020 — acetaminophen, 0363-6028 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 0363-6048 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-6142 — acetaminophen, dextromethorphan HBr, doxylamine succinate, and phenylephrine hydrochloride, 0363-6171 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-6190 — Acetaminophen, Dextromethorphan, 0363-6199 — acetaminophen, ibuprofen, 0363-6210 — Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine succinate, 0363-6238 — GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, 0363-6248 — Doxylamine Succinate, Phenylephrine Hydrochloride and Dextromethorphan Hydrobromide, 0363-6300 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 0363-6502 — Hemorrhoidal Cooling Gel, 0363-6503 — Hemorrhoidal Pain Relief, 0363-6504 — Acetaminophen and Dextromethorphan Hydrobromide, +4982 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.